Literature DB >> 7012615

The phospholipases of pathogenic and non-pathogenic Trypanosoma species.

P N Hambrey, A Mellors, I R Tizard.   

Abstract

Four species of trypanosome were examined for phospholipase activities using 1-[3H]palmitoyl-2-acyl-sn-glycero-3-phosphocholine and 1-acyl-2[14C]linoleoyl-sn-glycero-3-phosphocholine as substrates. The major activity in each species is a phospholipase A1 (EC 3.1.1.32) which does not require calcium. The most effective of the detergents tested for activation of the enzyme from each species, and the Ph optima, are as follows: Trypanosoma brucei, 0.125% Triton X-100 at pH 6.0-8.5; T. congolense, 0.5 mM linoleate at pH 6.0; T. theileri, 0.1% Triton X-100 at pH 6.75; T. lewisi, 0.2 mM sodium dodecyl sulfate at pH 5.2. The specific activity of the enzyme from a pathogenic species, T. brucei, is very high (145 nmol/min/mg/protein) and could contribute to the tissue damage characteristically caused by this parasite. The level in T. lewisi, a non-pathogenic species, is relatively low (1 nmol/min/mg). The levels in T. theileri (31 nmol/min/mg) and T. congolense (10 nmol/min/mg are intermediate. These results are compatible with the hypothesis that phospholipases contribute to the pathogenicity of trypanosomes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012615     DOI: 10.1016/0166-6851(81)90098-0

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  13 in total

1.  Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease.

Authors:  M Wainszelbaum; E Isola; S Wilkowsky; J J Cannata; J Florin-Christensen; M Florin-Christensen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Proteolysis of sialoglycoprotein by Pasteurella haemolytica cytotoxic culture supernatant.

Authors:  G L Otulakowski; P E Shewen; A E Udoh; A Mellors; B N Wilkie
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

3.  TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection.

Authors:  J Naessens; H Kitani; Y Nakamura; Y Yagi; K Sekikawa; F Iraqi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  The role and characterization of phospholipase A1 in mediating lysophosphatidylcholine synthesis in Trypanosoma brucei.

Authors:  Gregory S Richmond; Terry K Smith
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

5.  Evidence for phospholipases from Trypanosoma cruzi active on phosphatidylinositol and inositolphosphoceramide.

Authors:  L E Bertello; M J Alves; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

6.  A novel phospholipase from Trypanosoma brucei.

Authors:  Gregory S Richmond; Terry K Smith
Journal:  Mol Microbiol       Date:  2007-02       Impact factor: 3.501

7.  Novel protein candidates for serodiagnosis of African animal trypanosomosis: Evaluation of the diagnostic potential of lysophospholipase and glycerol kinase from Trypanosoma brucei.

Authors:  Magamba Tounkara; Alain Boulangé; Magali Thonnus; Frédéric Bringaud; Adrien Marie Gaston Bélem; Zakaria Bengaly; Sophie Thévenon; David Berthier; Loïc Rivière
Journal:  PLoS Negl Trop Dis       Date:  2021-12-17

8.  Calcium entry in Trypanosoma brucei is regulated by phospholipase A2 and arachidonic acid.

Authors:  J Eintracht; R Maathai; A Mellors; L Ruben
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

9.  Evidence for lipid-protein interactions in the attachment of antigens to a low-density membrane fraction isolated from Trypanosoma rhodesiense.

Authors:  J McLaughlin
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Free fatty acids released from phospholipids are the major heat-stable hemolytic factor of Entamoeba histolytica trophozoites.

Authors:  S Said-Fernández; R López-Revilla
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.